Literature DB >> 6376837

Effects of endurance training on glucose tolerance and plasma lipid levels in older men and women.

D R Seals, J M Hagberg, B F Hurley, A A Ehsani, J O Holloszy.   

Abstract

Eleven healthy men and women (63 +/- 1 years) participated in a 12-month endurance-training program to determine the effects of low-intensity and high-intensity training on glucose tolerance and plasma lipids in older persons. Plasma glucose, insulin, and C-peptide concentrations were measured for three hours after ingestion of 100 g of glucose and the total areas under the respective curves were calculated. Total plasma lipids and lipoprotein concentrations were determined during fasting. Maximal oxygen uptake increased 12% during six months of low-intensity training; a further 18% increase occurred during an additional six months of high-intensity training. Glucose tolerance, which was normal initially, was not significantly changed after training. However, the total area for insulin was 8% lower after low-intensity training, and 23% lower after high-intensity training, compared with before training. C-peptide concentrations were similarly reduced. Plasma lipid and lipoprotein concentrations were unchanged after low-intensity training, but high-intensity training resulted in an increase in high-density lipoprotein cholesterol and a reduction in triglycerides. These results demonstrate that older persons respond to prolonged, high-intensity endurance training with an increase in sensitivity to insulin and a favorable alteration in their plasma lipoprotein-lipid profile.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6376837

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  45 in total

Review 1.  Strength training in the elderly: effects on risk factors for age-related diseases.

Authors:  B F Hurley; S M Roth
Journal:  Sports Med       Date:  2000-10       Impact factor: 11.136

2.  Sex-specific effects of habitual aerobic exercise on brachial artery flow-mediated dilation in middle-aged and older adults.

Authors:  Gary L Pierce; Iratxe Eskurza; Ashley E Walker; Tara N Fay; Douglas R Seals
Journal:  Clin Sci (Lond)       Date:  2011-01       Impact factor: 6.124

3.  The effects of 24 weeks of moderate- or high-intensity exercise on insulin resistance.

Authors:  Gary O'Donovan; Edward M Kearney; Alan M Nevill; Kate Woolf-May; Steve R Bird
Journal:  Eur J Appl Physiol       Date:  2005-09-06       Impact factor: 3.078

4.  Health care trends for older people.

Authors:  T F Williams
Journal:  Biofeedback Self Regul       Date:  1991-12

Review 5.  Muscle mitochondrial changes with aging and exercise.

Authors:  Ian R Lanza; K Sreekumaran Nair
Journal:  Am J Clin Nutr       Date:  2008-12-03       Impact factor: 7.045

Review 6.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

7.  Exercise intensity and insulin sensitivity: how low can you go?

Authors:  J A Hawley; M J Gibala
Journal:  Diabetologia       Date:  2009-06-26       Impact factor: 10.122

8.  Adverse effect of the anabolic-androgenic steroid mesterolone on cardiac remodelling and lipoprotein profile is attenuated by aerobicz exercise training.

Authors:  Karina Fontana; Helena Coutinho Franco Oliveira; Marta Beatriz Leonardo; Carlos Alberto Mandarim-de-Lacerda; Maria Alice da Cruz-Höfling
Journal:  Int J Exp Pathol       Date:  2008-10       Impact factor: 1.925

Review 9.  Rate and mechanism of maximal oxygen consumption decline with aging: implications for exercise training.

Authors:  Steven Hawkins; Robert Wiswell
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

10.  A community-based approach to trials of aerobic exercise in aging and Alzheimer's disease.

Authors:  Eric D Vidoni; Angela Van Sciver; David K Johnson; Jinghua He; Robyn Honea; Brian Haines; Jami Goodwin; M Pat Laubinger; Heather S Anderson; Patricia M Kluding; Joseph E Donnelly; Sandra A Billinger; Jeffrey M Burns
Journal:  Contemp Clin Trials       Date:  2012-08-07       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.